KRAS and colorectal cancer: In the colorectal cancer setting, preclinical in vitro models of resistance to the anti-EGFR mAbs cetuximab and panitumumab include cell lines showing mutations of the K-Ras gene, most frequently in codon 12 of exon 2, such as SW480, LS174T, HCT116, LoVo cells.